Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Present At The Cowen 38th Annual Healthcare Conference

BOULDER, Colo., March 5, 2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Cowen 38th Annual Healthcare Conference in Boston.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   


Cowen 38th Annual Healthcare Conference


Ron Squarer, Chief Executive Officer, Array BioPharma


Monday, March 12, 2018


11:20 a.m. Eastern Time


About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).  For more information on Array, please go to

Andrea N. Flynn, Ph.D.
Senior Director, Investor Relations & Corporate Communications
(303) 381-6600

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)


Cision View original content with multimedia:

SOURCE Array BioPharma Inc.